LGD-4033 / Ligandrol

Ergogenic

Lean-mass increase positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: SARM
Primary mechanism: Androgen receptor modulator
Primary market use: Muscle wasting/performance

Pharmacology

Molecular weight (Da): 338.3
Oral bioavailability: High
Half-life: ~24-36 h
Route tags: SubQ; Injectable; route-dependent
Evidence level: Clinical/research
Clinical status: Investigational/prohibited in sport
Value-for-money score: 3 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Non-peptide; effects regress without training/continued use

Sources

https://www.wada-ama.org/en/prohibited-list